ÍÑÒÂÖ±²¥

The purpose of the study is to test if an experimental drug called ATH-1017 is safe and helpful to people with memory and thinking problems associated with Alzheimer's Disease. The study treatments, ATH-1017 or a placebo, will be assigned randomly. Nationwide, 300 participants will be recruited for this study. At ÍÑÒÂÖ±²¥, we expect to recruit up to 15 participants.

In order to participate, you must:

• Be 55-85 years old.
• Have a diagnosis of mild to moderate Alzheimer's Disease.
• Have an individual who knows you well willing to take part in the study with you as your study partner.

You will be excluded from the study if you:

• Are unable or unwilling to complete all study activities.
• Have other medical conditions, illnesses or diseases that could interfere with study participation.

This is a partial list of inclusion and exclusion criteria.